Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02.
about
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Phase II trial of miniDOX (red ...... stric cancer (AGC). TTD 08-02.
@en
type
label
Phase II trial of miniDOX (red ...... stric cancer (AGC). TTD 08-02.
@en
prefLabel
Phase II trial of miniDOX (red ...... stric cancer (AGC). TTD 08-02.
@en
P2093
P2860
P1476
Phase II trial of miniDOX (red ...... stric cancer (AGC). TTD 08-02.
@en
P2093
A L Yuste Izquierdo
J L Manzano
J Martínez Galán
P2860
P2888
P304
P356
10.1007/S00280-014-2641-3
P577
2014-12-10T00:00:00Z
P6179
1010118398